Reducing Methicillin-Resistant Staphylococcus aureus (MRSA) Infections

被引:22
作者
Griffin, Frances A. [1 ]
机构
[1] Inst Healthcare Improvement, Mill Lives Campaign 5, Cambridge, MA 02138 USA
关键词
D O I
10.1016/S1553-7250(07)33087-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Hospital-acquired infections from methicillin-resistant Staphylococcus aureus (MRSA) now account for more than 60% of S. aureus infections in intensive care patients reported to the Centers for Disease Control and Prevention (CDC). Media stories have raised the profile of this problem, and several states have moved toward legislative action regarding screening of hospital patients or mandatory reporting of infections. Guidelines from clinical expert organizations, including the CDC, the Association for Professionals in Infection Control and Epidemiology (APIC), and the Society for Healthcare Epidemiology of America (SHEA), recommend the use of basic prevention practices to avoid transmission in the hospital setting, yet concerns persist that compliance with these practices is neither consistent nor reliable. Intervention: The campaign's MRSA intervention recommends five key components of care. These are not intended to be an all-inclusive list but rather have been recommended by experts as the minimum necessary components: (1) hand hygiene, (2) decontamination of the environment and equipment, (3) active surveillance, (4) contact precautions for infected and colonized patients, and (5) device bundles (central line bundle and ventilator bundle). Conclusion: The IHI's 5 Million Lives Campaign considers all hospital-acquired infections as harm to patients, and reduction of MRSA is one of the areas of focus.
引用
收藏
页码:726 / 731
页数:6
相关论文
共 42 条
[1]  
[Anonymous], 2006, MANAGEMENT MULTIDRUG
[2]  
Association for Professionals in Infection Control and Epidemiology, 2007, GUID EL METH RES STA
[3]  
Berwick D., 2006, I HEALTHCARE IMPROVE
[4]   Handwashing compliance by health care workers -: The impact of introducing an accessible, alcohol-based hand antiseptic [J].
Bischoff, WE ;
Reynolds, TM ;
Sessler, CN ;
Edmond, MB ;
Wenzel, RP .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (07) :1017-1021
[5]   Controlling methicillin-resistant Staphylococcus aureus:: Quantifying the effects of interventions and rapid diagnostic testing [J].
Bootsma, MCJ ;
Diekmann, O ;
Bonten, MJM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (14) :5620-5625
[6]  
Boyce JM, 1997, INFECT CONT HOSP EP, V18, P622
[7]  
*CDCP, METH OX RES STAPH AU
[8]   Control of endemic methicillin-resistant Staphylococcus aureus -: A cost-benefit analysis in an intensive care unit [J].
Chaix, C ;
Durand-Zaleski, I ;
Alberti, C ;
Brun-Buisson, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (18) :1745-1751
[9]   Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (XMSA):: Systematic review of the literature [J].
Cooper, BS ;
Stone, SP ;
Kibbler, CC ;
Cookson, BD ;
Roberts, JA ;
Medley, GF ;
Duckworth, G ;
Lai, R ;
Ebrahim, S .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7465) :533-538
[10]   Identifying groups at high risk for carriage of antibiotic-resistant bacteria [J].
Furuno, JP ;
McGregor, JC ;
Harris, AD ;
Johnson, JA ;
Johnson, JK ;
Langenberg, P ;
Venezia, RA ;
Finkelstein, J ;
Smith, DL ;
Strauss, SM ;
Perencevich, EN .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (05) :580-585